Imuran should not be given during pregnancy without careful weighing
of risk versus benefit. Whenever possible,
use of Imuran
in pregnant patients should be avoided. This drug should not be used for treating rheumatoid arthritis in pregnant women.
Prednisone has not been formally assigned to a pregnancy category by the FDA.
However, its active metabolite, prednisoLONE, has been assigned to pregnancy category C by the FDA.